[Journal logo]

Volume 64 
Part 12 
Page o2290  
December 2008  

Received 19 September 2008
Accepted 31 October 2008
Online 8 November 2008

Key indicators
Single-crystal X-ray study
T = 100 K
Mean [sigma](C-C) = 0.002 Å
R = 0.031
wR = 0.083
Data-to-parameter ratio = 17.8
Details
Open access

Dimethyl 3-acetyl-3-(1,3-benzothiazol-2-yl)pentanedioate

aLaboratoire de Chimie Organique et Études Physicochimiques, ENS Rabat, Morocco,bLaboratoire de Chimie Organique Hétérocyclique, Université Mohammed V Rabat, Morocco, and cInstitute of Chemistry, University of Osnabrück, Barbarastrasse 7, D-49069 Osnabrück, Germany
Correspondence e-mail: hreuter@uos.de

The title compound, C16H17NO5S, was one of two condensation products from the reaction of 1-(1,3-benzothiazol-2-yl)propan-2-one with methyl chloroacetate. The non-H atoms in each of the four substituent groups on the central quaternary C atom are virtually coplanar. The maximum deviations from the least-squares planes are 0.015 (2) and 0.020 (2) Å for the methyl C atoms in the methyl acetate substituents and 0.033 (1) Å for the linked C atom of the benzothiazole substituent. The S, C and N atoms in the thiazole ring of the benzothiazole substituent lie -0.037 (2), 0.046 (2) and -0.028 (2) Å, respectively, from the mean plane defined by the benzene ring atoms.

Related literature

For general background, see: Palmer et al. (1971[Palmer, P. J., Trigg, R. B. & Warrington, J. V. (1971). J. Med. Chem. 14, 248-251.]); Bénéteau et al., 1999[Bénéteau, V., Besson, T., Guillard, J., Léonce, S. & Pfeiffer, B. J. (1999). Eur. J. Med. Chem. 34, 1053-1060.]; El-Sherbeny (2000[El-Sherbeny, M. A. (2000). Arzneim. Forsch. 50, 848-853.]); Abayeh et al. (1994[Abayeh, O. J., Olagbemiro, T. O., Agho, M. O. & Amupitan, J. O. (1994). Bull. Soc. Chim. Belg. 103, 687-690.]); Ivanov & Yuritsyn (1971[Ivanov, S. V. & Yuritsyn, V. S. (1971). Neftekhimiya, 11, 99-107.]); Monsanto (1968[Monsanto, C. O. (1968). Br. Patent No. 1 106 577.]); Lee et al. (2001[Lee, C. L., Lam, Y. & Lee, S.-Y. (2001). Tetrahedron Lett. 42, 109-111.]). For related structures, see: Chen (1994[Chen, W. (1994). J. Organomet. Chem. 471, 69-70.]); Chu et al. (2003[Chu, Q., Wang, Z., Huang, Q., Yan, C. & Zhu, S. (2003). New J. Chem. 27, 1522-1527.]).

[Scheme 1]

Experimental

Crystal data
  • C16H17NO5S

  • Mr = 335.37

  • Monoclinic, P 21 /c

  • a = 14.4075 (3) Å

  • b = 8.8089 (2) Å

  • c = 13.8968 (3) Å

  • [beta] = 118.011 (1)°

  • V = 1557.10 (6) Å3

  • Z = 4

  • Mo K[alpha] radiation

  • [mu] = 0.23 mm-1

  • T = 100 (2) K

  • 0.54 × 0.47 × 0.25 mm

Data collection
  • Bruker APEXII CCD area-detector diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 2004[Bruker (2004). SADABS and SMART. Bruker AXS Inc., Madison, Wisconsin, USA.]) Tmin = 0.883, Tmax = 0.945

  • 94263 measured reflections

  • 3766 independent reflections

  • 3396 reflections with I > 2[sigma](I)

  • Rint = 0.030

Refinement
  • R[F2 > 2[sigma](F2)] = 0.030

  • wR(F2) = 0.083

  • S = 1.02

  • 3766 reflections

  • 211 parameters

  • H-atom parameters constrained

  • [Delta][rho]max = 0.40 e Å-3

  • [Delta][rho]min = -0.23 e Å-3

Data collection: SMART (Bruker, 2004[Bruker (2004). SADABS and SMART. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: SAINT (Bruker, 2007[Bruker (2007). SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: DIAMOND (Brandenburg, 1999[Brandenburg, K. (1999). DIAMOND. Crystal Impact GbR, Bonn, Germany.]); software used to prepare material for publication: SHELXTL (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]).


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: FJ2155 ).


References

Abayeh, O. J., Olagbemiro, T. O., Agho, M. O. & Amupitan, J. O. (1994). Bull. Soc. Chim. Belg. 103, 687-690.  [ChemPort]
Bénéteau, V., Besson, T., Guillard, J., Léonce, S. & Pfeiffer, B. J. (1999). Eur. J. Med. Chem. 34, 1053-1060.
Brandenburg, K. (1999). DIAMOND. Crystal Impact GbR, Bonn, Germany.
Bruker (2004). SADABS and SMART. Bruker AXS Inc., Madison, Wisconsin, USA.
Bruker (2007). SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
Chen, W. (1994). J. Organomet. Chem. 471, 69-70.  [ChemPort]
Chu, Q., Wang, Z., Huang, Q., Yan, C. & Zhu, S. (2003). New J. Chem. 27, 1522-1527.  [ISI] [CSD] [CrossRef] [ChemPort]
El-Sherbeny, M. A. (2000). Arzneim. Forsch. 50, 848-853.  [ChemPort]
Ivanov, S. V. & Yuritsyn, V. S. (1971). Neftekhimiya, 11, 99-107.  [ChemPort]
Lee, C. L., Lam, Y. & Lee, S.-Y. (2001). Tetrahedron Lett. 42, 109-111.  [ISI] [CrossRef] [ChemPort]
Monsanto, C. O. (1968). Br. Patent No. 1 106 577.
Palmer, P. J., Trigg, R. B. & Warrington, J. V. (1971). J. Med. Chem. 14, 248-251.  [CrossRef] [ChemPort] [PubMed] [ISI]
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]


Acta Cryst (2008). E64, o2290  [ doi:10.1107/S1600536808035782 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.